Referencias

Bedi, G., Hyman, D., & Wit, H. D. (2010). Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others. Biological Psychiatry, 68(12), 1134-1140.

Bedi, G., Phan, K. L., Angstadt, M., & Wit, H. D. (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology, 207(1), 73-83.

Degenhardt, L., Bruno, R., & Topp, L. (2009). Is Ecstasy A Drug Of Dependence?. Drug and Alcohol Dependence, 107(1), 1-10.

Frye, C. G., Wardle, M. C., Norman, G. J., & Wit, H. D. (2014). MDMA decreases the effects of simulated social rejection. Pharmacology Biochemistry and Behavior, 117, 1-6.

Karageorgiou, J., Dietrich, M. S., Charboneau, E. J., Woodward, N. D., Blackford, J. U., Salomon, R. M., et al. (2009). Prior MDMA (Ecstasy) use is associated with increased basal ganglia–thalamocortical circuit activation during motor task performance in humans: An fMRI study. NeuroImage, 46(3), 817-826.

Krolikowski, A. M., & Koyfman, A. (2013). Methamphetamine and MDMA: ‘Safe’ drugs of abuse. African Journal of Emergency Medicine, 4(1), 34-38.

Morris, K. (2013). Enter the shamans of science and the psychonauts of psychiatry. The Lancet, 381(9866), 526.

Parrott, A. C. (2013). MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users. Neuroscience & Biobehavioral Reviews, 37(8), 1466-1484.

Perna, E. D., Theunissen, E., Kuypers, K., Heckman, P., Torre, R. D., Farre, M., et al. (2014). Memory and mood during MDMA intoxication, with and without memantine pretreatment. Neuropharmacology, xxx, 1-8.

Reuter-Rice, K. (2009). Ecstasy in the Emergency Department: MDMA Ingestion. Journal of Pediatric Health Care, 23(1), 49-53.

Sessa, B. (2012). Shaping the renaissance of psychedelic research. The Lancet, 380(9838), 200-201.